NDA9/00916.058 - Support to Beacon Project: Group Planning Capability

Award

Value

£300,000

Suppliers

Classifications

  • Research and development services and related consultancy services

Tags

  • award

Submission Deadline

4 months ago

Published

4 months ago

Description

The NDA Group does not currently have a Group-level strategic planning capability nor an approach to model 'what if' scenarios and evaluate 
their mission benefit or disbenefit at group and/or opco levels. Historically, strategic planning capabilities were held by Parent Body Organisations (PBO's) of OpCo's, with each OpCo having its own planning capability, including creating and maintaining Lifetime Plans. Today, the OpCo Lifetime Plans remain separate data sets at different states of maturity (e.g. scope, accuracy, logic, integrity of data, underpinning assumptions) preventing the simulation of 'what-if' interventions at the Group level. 
To predict the impact of one or multiple 'what-if' scenarios across an aggregated picture of the estate (above the individual OpCo Lifetime Plans) will require the creation of a Group mission plan, against which scenarios can be modelled. By creating a Group 
planning capability around this Group mission plan, we will be able to model and consider group portfolio trade-offs and inter-group dependencies and translate our strategic decisions into delivery through OpCo delivery plans.
To respond to this need and realise the benefits of the OneNDA model and closer working relationships, the group has confirmed the need to develop a Group planning capability, which will be the objective of a multi-year Beacon Project commencing in April 2024.
We aim to design and implement a consistent Group-level approach to planning, driven by quality financial and operational / activity data. It will consider how all elements of planning across the group are conducted and how various elements contribute to meeting the NDA mission.  Beyond the work completed to date, below describes the further development work required to successfully deliver Year 1 of the Beacon Project and the associated 
'Stretch' measures/commitments made in the Group Key Target (GKT): 
This engagement has two primary objectives: 
1. To support the Beacon project working group to identify, design and implement a suite 
of management arrangements to establish and maintain the initial group planning 
capability and Group Mission Plan upon which it relies. 
2. To design and facilitate to conclusion, a scenario modelling event that considers one 
scenario (likely comprising several interventions) in order to determine and present in 
a report the mission benefits and disbenefits of said scenario in

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

Open

NICE External Assessment Groups Framework

NICE is seeking to commission external assessment groups (EAGs) which will provide a range of services to support its programmes and related activities. Suppliers can bid for one or more Lots. NICE will consider bids from multidisciplinary EAGs with knowledge and expertise in health technology assessment. NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services. Main activities of the EAGs in each framework NICE commissions EAGs to support its guidance development programmes in the following key areas and tasks: Lot 1 - Clinical and Economic Evidence Assessment Including: critical appraisal of clinical and economic evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; systematic review and meta-analysis; supporting scoping of evaluation topics; user preference assessment or structured elicitation, confirmation and review of regulatory status to the evaluation programmes. Lot 2 - Technical and Decision Support Including: providing advanced methodological and analytical advice and support to NICE's technical teams and committees on all guideline and technology types that are in remit for NICE, including Health Technology Evaluation (HTE) outputs (pharmaceuticals, diagnostics, medical device and digital technologies, combination products etc.) and Guidelines topics covering public health, social and clinical areas. This includes providing evidence synthesis, data analytics, complex decision analytical modelling and health economic support; providing a technical rapid response service and quality assurance input for guidance products; development and provision of guidance methods training, covering evidence synthesis, data analytics, decision analytical modelling and health economics. Lot 3 - Evidence Generation to support Access Including: Evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; data linkage and complex modelling and/or analyses; register set up and close. Lot 4 Research governance & ethics support Including: advice on research governance and ethics support including access to a research ethics committee.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete